2025 Drug List (Therapeutic Class Drug List) for BCBS Oklahoma
Comprehensive 2025 pharmacy drug list for Blue Cross and Blue Shield of Oklahoma describing covered drugs, tier placements, special requirements (PA, QL, ST, AC, SP), dispensing/quantity limits, step therapy/prior authorization processes, exception and expedited review processes, and member/provider guidance. This part contains introductory material, selection criteria, coverage considerations and a portion of the therapeutic class/drug listing (anti-infective agents through antivirals).
No material clinical or coverage changes in this update.
Coverage Summary & Scope
General Coverage / Exception / Prior Authorization / Step Therapy Rules
General Coverage, Exception, Prior Authorization, and Step Therapy rules applicable at the plan level — operational definitions, timelines, and distinctions between pharmacy and medical benefits.
ALL of the following
- Coverage is subject to the member’s benefit plan document; presence on this drug list means the product is available under the pharmacy benefit unless otherwise noted (for example, medical benefit adminstration or exclusion).
- Prior Authorization (PA): When a PA is required, the prescriber must submit a prior authorization request and supporting clinical information. PA decisions follow applicable timelines: standard determinations are completed within 15 calendar days; expedited (urgent) requests are completed within 72 hours when the prescriber indicates that waiting for a standard review could seriously jeopardize the member’s health.
- Step Therapy (ST): When ST is required, the member must try and fail (or be contraindicated/intolerant to) specified lower‑cost or clinically preferred alternatives before coverage for the requested drug is approved. ST programs and allowed exceptions are defined at the product level and in plan materials.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.